Scarica l'app Stockscreener
20.93
2.55%
0.52
Dopo l'orario di chiusura:
20.93
Precedente Chiudi:
$20.41
Aprire:
$20.49
Volume 24 ore:
330.85K
Relative Volume:
0.89
Capitalizzazione di mercato:
$776.41M
Reddito:
-
Utile/perdita netta:
-
Rapporto P/E:
-
EPS:
-
Flusso di cassa netto:
-
1 W Prestazione:
+6.14%
1M Prestazione:
+62.88%
6M Prestazione:
+15.13%
1 anno Prestazione:
-28.32%
Intervallo 1D:
$20.20
$21.07
Intervallo di 1 settimana:
$19.52
$24.25
Portata 52W:
$10.01
$29.96
Ceribell Inc Stock (CBLL) Company Profile
Nome
Ceribell Inc
Settore
Industria
Telefono
(800) 436-0826
Indirizzo
360 N. PASTORIA AVENUE, SUNNYVALE
Confronta CBLL con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CBLL
Ceribell Inc
|
20.93 | 757.12M | 0 | 0 | 0 | 0.00 |
|
ABT
Abbott Laboratories
|
125.46 | 214.37B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
92.58 | 136.01B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
354.09 | 134.98B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
99.87 | 127.88B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
83.08 | 48.88B | 5.88B | 1.34B | 799.60M | 2.3489 |
Ceribell Inc Stock (CBLL) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-10-21 | Iniziato | Raymond James | Strong Buy |
| 2025-06-24 | Iniziato | BTIG Research | Buy |
| 2025-04-04 | Iniziato | Ladenburg Thalmann | Buy |
| 2024-11-05 | Iniziato | BofA Securities | Buy |
| 2024-11-05 | Iniziato | Canaccord Genuity | Buy |
| 2024-11-05 | Iniziato | JP Morgan | Overweight |
| 2024-11-05 | Iniziato | TD Cowen | Buy |
| 2024-11-05 | Iniziato | William Blair | Outperform |
Mostra tutto
Ceribell Inc Borsa (CBLL) Ultime notizie
Ceribell extends leases for Sunnyvale offices through January 2028 By Investing.com - Investing.com Nigeria
Insider Selling: CeriBell (NASDAQ:CBLL) Director Sells 32,728 Shares of Stock - MarketBeat
FDA Clears Ceribell’s AI-Powered EEG as First Device for Continuous Delirium Monitoring - HIT Consultant
Ceribell, Inc. Extends Sunnyvale Office Leases - TipRanks
Ceribell extends leases for Sunnyvale offices through January 2028 - Investing.com
CBLL Gets FDA Consent for One-of-a-Kind Delirium Monitoring Solution - Yahoo Finance
Josef Parvizi Sells 25,000 Shares of CeriBell (NASDAQ:CBLL) Stock - MarketBeat
Ceribell receives FDA 510K clearance for delirium screening, monitoring device - MSN
CeriBell (NASDAQ:CBLL) Shares Down 5.4% on Insider Selling - MarketBeat
Risk Analysis: Will CeriBell Inc stock split attract more investorsEarnings Miss & Verified Short-Term Trading Plans - moha.gov.vn
Insider Selling: CeriBell (NASDAQ:CBLL) Director Sells 5,000 Shares of Stock - MarketBeat
Ceribell director Robertson sells $100k in CBLL stock By Investing.com - Investing.com South Africa
Ceribell director Robertson sells $100k in CBLL stock - Investing.com
FDA OKs Ceribell’s Delirium Monitoring Solution - Medical Product Outsourcing
Buy Rating Affirmed for Ceribell, Inc. Due to Innovative Neonate Technology and FDA Clearance - TipRanks
Ceribell, Inc.’s Delirium Solution Gains Early FDA Clearance, Boosting Market Potential and Supporting Buy Rating - TipRanks
Ceribell, Inc. (CBLL) Gets a Buy from TD Cowen - The Globe and Mail
There's Reason For Concern Over CeriBell, Inc.'s (NASDAQ:CBLL) Massive 69% Price Jump - 富途牛牛
CeriBell (NASDAQ:CBLL) Shares Gap UpTime to Buy? - MarketBeat
Ceribell stock price target raised to $29 from $20 at TD Cowen on FDA clearance - Investing.com
CeriBell Says FDA Clears Delirium Monitoring Solution; Shares Rise - marketscreener.com
Ceribell, Inc. Gains FDA Clearance for Delirium Device - TipRanks
Ceribell jumps on FDA clearance of brain monitoring device - TradingView — Track All Markets
Ceribell, Inc. Receives FDA Clearance for Delirium Monitoring Solution - TradingView — Track All Markets
Ceribell receives FDA 510k clearance for delirium screening, monitoring device - TipRanks
FDA clears Ceribell’s delirium monitoring system for ICU patients - Investing.com
FDA clears Ceribell’s delirium monitoring system for ICU patients By Investing.com - Investing.com India
Ceribell Receives FDA 510(k) Clearance for First-of-its-Kind Delirium Monitoring Solution - The Manila Times
Ceribell CEO Chao Xingjuan sells $470k in CBLL stock By Investing.com - Investing.com Canada
CeriBell (NASDAQ:CBLL) CEO Sells $470,500.00 in Stock - MarketBeat
Ceribell CEO Chao Xingjuan sells $470k in CBLL stock - Investing.com
Ceribell Insider Sold Shares Worth $470,500, According to a Recent SEC Filing - marketscreener.com
David Foehr Sells 5,265 Shares of CeriBell (NASDAQ:CBLL) Stock - MarketBeat
Ceribell’s Foehr David sells $88k in Ceribell stock By Investing.com - Investing.com Australia
Ceribell’s Foehr David sells $88k in Ceribell stock - Investing.com India
Ceribell Senior VP David Foehr Sells 5,265 Shares - TradingView
VP Foehr Sells 5,265 ($88.6K) Of CeriBell Inc [CBLL] - TradingView
Insider Selling: CeriBell (NASDAQ:CBLL) Director Sells 827 Shares of Stock - MarketBeat
Geode Capital Management LLC Has $8.39 Million Stock Position in CeriBell, Inc. $CBLL - MarketBeat
CEO Chao Files To Sell 25,000 Of CeriBell Inc [CBLL] - TradingView
Robertson of Ceribell sells $13k in shares By Investing.com - Investing.com Nigeria
Insider Selling: CeriBell (NASDAQ:CBLL) CEO Sells 25,000 Shares of Stock - MarketBeat
CeriBell (NASDAQ:CBLL) CTO Sells $136,455.36 in Stock - MarketBeat
Robertson of Ceribell sells $13k in shares - Investing.com
Ceribell Director Rebecca B. Robertson Sells 827 Shares - TradingView
Chmn Robertson Sells 827 ($13.8K) Of CeriBell Inc [CBLL] - TradingView
CeriBell, Inc. (CBLL) Presents at Piper Sandler 37th Annual Healthcare ConferenceSlideshow - Seeking Alpha
Ceribell’s Woo Raymond sells $136k in shares By Investing.com - Investing.com Australia
Ceribell management to meet virtually with BTIG - MSN
Ceribell’s Woo Raymond sells $136k in shares - Investing.com
Ceribell Inc Azioni (CBLL) Dati Finanziari
Non sono disponibili dati finanziari per Ceribell Inc (CBLL). Controlla altri titoli per ulteriori informazioni.
Reddito
Reddito netto
Flusso di cassa
EPS
0.52%
0.28%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):